An additional study reported a significant correlation between elevated TRAP5b concentrations, reduced BSAP levels and higher arterial stiffness, suggesting that the disparity between bone resorption and formation in CKD, inferred by the TRAP5b:BSAP ratio, is prognostic of vascular stiffness in non-dialysis patients [109]. Here, PAX5 is linked to chronic kidney disease.